stoxline Quote Chart Rank Option Currency Glossary
  
GE HealthCare Technologies Inc. (GEHC)
92.52  -0.15 (-0.16%)    02-19 16:00
Open: 92.28
High: 93.15
Volume: 3,260,835
  
Pre. Close: 92.67
Low: 91.6
Market Cap: 42,270(M)
Technical analysis
2025-02-19 4:17:47 PM
Short term     
Mid term     
Targets 6-month :  110.72 1-year :  129.32
Resists First :  94.8 Second :  110.72
Pivot price 88.98
Supports First :  87.42 Second :  82.86
MAs MA(5) :  91.35 MA(20) :  88.78
MA(100) :  85.92 MA(250) :  84.72
MACD MACD :  1.9 Signal :  1.5
%K %D K(14,3) :  74.9 D(3) :  69.4
RSI RSI(14): 65.2
52-week High :  94.8 Low :  74.51
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ GEHC ] has closed below upper band by 13.1%. Bollinger Bands are 44.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 93.34 - 94 94 - 94.51
Low: 90.88 - 91.59 91.59 - 92.13
Close: 91.76 - 92.84 92.84 - 93.68
Company Description

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Headline News

Wed, 19 Feb 2025
Empowered Funds LLC Grows Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) - MarketBeat

Tue, 18 Feb 2025
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Short Interest Down 24.1% in January - MarketBeat

Mon, 17 Feb 2025
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Q4 2024 Earnings Call Transcript - Insider Monkey

Mon, 17 Feb 2025
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Asset Management One Co. Ltd. - MarketBeat

Mon, 17 Feb 2025
GE HealthCare Technologies (NASDAQ:GEHC) Trading Up 7.4% After Earnings Beat - MarketBeat

Sat, 15 Feb 2025
GE HealthCare Technologies Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 457 (M)
Shares Float 456 (M)
Held by Insiders 0.4 (%)
Held by Institutions 88 (%)
Shares Short 9,690 (K)
Shares Short P.Month 12,150 (K)
Stock Financials
EPS 4.34
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 18.47
Profit Margin 10.1 %
Operating Margin 16.6 %
Return on Assets (ttm) 5.7 %
Return on Equity (ttm) 25.6 %
Qtrly Rev. Growth 2.2 %
Gross Profit (p.s.) 17.95
Sales Per Share 43.01
EBITDA (p.s.) 7.89
Qtrly Earnings Growth 78.4 %
Operating Cash Flow 1,950 (M)
Levered Free Cash Flow 1,860 (M)
Stock Valuations
PE Ratio 21.31
PEG Ratio 0
Price to Book value 5
Price to Sales 2.15
Price to Cash Flow 21.69
Stock Dividends
Dividend 0.03
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android